Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 612 studies with search of: | "Dyskinesias" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Active, not recruiting |
Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1)
|
||||
2 | Recruiting |
Ultrasound for Diagnosis of Biliary Dyskinesia
|
||||
3 | Completed |
Levetiracetam Treatment of L-Dopa Induced Dyskinesias
|
||||
4 | Completed |
Sarizotan in Parkinson Patients With L-Dopa-Induced Dyskinesia
|
||||
5 | Completed |
Sarizotan HCl in Patients With Parkinson's Disease Suffering From Treatment-Associated Dyskinesia
|
||||
6 | Completed |
Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-Associated Dyskinesia
|
||||
7 | Active, not recruiting |
Levetiracetam Administration for the Management of Levodopa-Induced Dyskinesias in Parkinson's Disease
|
||||
8 | Completed |
Levetiracetam in the Treatment of Neuroleptic-Induced Tardive Dyskinesia
|
||||
9 | Completed |
Ethyl-Eicosapentaenoic Acid and Tardive Dyskinesia
|
||||
10 | Completed |
Genetic Study of Patients With Primary Ciliary Dyskinesia
|
||||
11 | Recruiting |
Efficacy of Docosahexaenoic Acid on Tardive Dyskinesia
|
||||
12 | Completed |
Extract of Ginkgo Biloba and Tardive Dyskinesia
|
||||
13 | Completed |
Piracetam for Treatment Tardive Dyskinesia
|
||||
14 | Completed |
Treatment of Tardive Dyskinesia With Galantamine
|
||||
15 | Completed |
Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia
|
||||
16 | Terminated |
Sarizotan in the Treatment of Neuroleptic-Induced Tardive Dyskinesia
|
||||
17 | Recruiting |
Dyskinesia, Heterotaxy and Congenital Heart Disease
|
||||
18 | Completed |
Effects of Talampanel on Patients With Advanced Parkinson's Disease
|
||||
19 | Not yet recruiting |
Diagnosis of Primary Ciliary Dyskinesia
|
||||
20 | Completed |
Effects of Atypical Versus Conventional Antipsychotics on the Prevalence of Tardive Dyskinesia
|
Previous Page | Studies Shown (1-20) | Next (21-40) |